Alumis Inc. ALMS
6.50 USD +0.12 (+1.88%)
At closeNov 3, 2026, 5:48 PM EST
6.56 +0.06 +0.92%
After hours · Nov 3, 5:48 PM ET
6.22 Day range 6.61
4.40 52-week range 31.35
- YTD
- -33.40%
- 1 year
- +42.54%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 32.13 +394.2% upside
Now 6.50
- Target (low)
- 15.00
- Target (mean)
- 32.13
- Target (high)
- 46.00
Ratings (0m) 10 9 buy · 1 hold · 0 sell
- Strong buy1
- Buy8
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.75 | -0.80 – -0.70 | -1.06 | +29.3% | 1.69M | -18.3% | 3 |
| Next quarter | -0.72 | -0.78 – -0.64 | -0.2526 | -185.0% | 1.69M | -12.4% | 3 |
| Current year | -3.32 | -3.44 – -3.23 | -4.60 | +27.9% | 6.26M | -74.0% | 3 |
| Next year | -2.87 | -3.09 – -2.62 | -3.32 | +13.5% | 24.33M | +288.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 3, 2026 | Guggenheim | Downgrade | Buy | Neutral |
| Sep 2, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 2, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 2, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 2, 2026 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Aug 14, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 3, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 19, 2026 | Chardan Capital | Maintained | Buy | Buy |
| May 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 15, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 15, 2026 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 30, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 30, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 30, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 20, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 11, 2026 | Raymond James | Initiated | — | Strong Buy |
| Feb 25, 2026 | Stifel | Initiated | — | Buy |
| Jan 21, 2026 | Chardan Capital | Initiated | — | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 7, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jan 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 7, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 18, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 15, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 25, 2025 | Wells Fargo | Initiated | — | Overweight |
| Jul 25, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2025 | Oppenheimer | Maintained | Outperform | Outperform |